PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills California, developing its compound RP-323, a gene repair therapy. A number of indications are under development which are all categorized as inflammatory disorders. It has been determined that RP-323 is active along specific cell lines, being able to target damaged or mutated cells due to cancer, viruses and a variety of other factors. Our studies ...
PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills California, developing its compound RP-323, a gene repair therapy. A number of indications are under development which are all categorized as inflammatory disorders. It has been determined that RP-323 is active along specific cell lines, being able to target damaged or mutated cells due to cancer, viruses and a variety of other factors. Our studies include cancer cells, blood cells and due to its special ability to pass through the Blood Brain Barrier (BBB), neurological cells.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.